Letters To The Editor
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. May 8, 2016; 8(13): 605-606
Published online May 8, 2016. doi: 10.4254/wjh.v8.i13.605
Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after surgery: A comment for moving forward
Jian-Hong Zhong, Tian Yang, Bang-De Xiang, Le-Qun Li, Liang Ma
Jian-Hong Zhong, Bang-De Xiang, Le-Qun Li, Liang Ma, Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
Tian Yang, Department of Hepatobiliary Surgery, Eastern Hepa-tobiliary Surgery Hospital, Second Military Medical University, Shanghai 201800, China
Author contributions: Zhong JH, Yang T and Xiang BD contributed equally to this work; Zhong JH designed the study and wrote the manuscript; Zhong JH, Yang T, Xiang BD, Li LQ and Ma L analyzed the data; all authors reviewed the manuscript.
Supported by The Guangxi University of Science and Tech-nology Research Projects, No. KY2015LX056; the Self-Raised Scientific Research Fund of the Ministry of Health of Guangxi Zhuang Autonomous Region, No. Z2015621, and No. Z2014241; the Innovation Project of Guangxi Graduate Education, No. YCBZ2015030; and the Guangxi Science and Technology Development Projects, No. 14124003-4.
Conflict-of-interest statement: The authors declare no conflicts of interest regarding this manuscript.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Liang Ma, MD, Department of Hepato-biliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, He Di Rd #71, Nanning 530021, Guangxi Zhuang Autonomous Region, China. xitongpingjia@163.com
Telephone: +86-771-5330855 Fax: +86-771-5312000
Received: February 18, 2016
Peer-review started: February 19, 2016
First decision: March 1, 2016
Revised: March 4, 2016
Accepted: March 22, 2016
Article in press: March 23, 2016
Published online: May 8, 2016
Processing time: 76 Days and 0.8 Hours
Core Tip

Core tip: Some important points about the usage of nucleos(t)ide analogues for patients with hepatocellular carcinoma after surgery in clinic were pointed out.